Lee A Coney

In vitro cytokine release assays: reducing the risk of adverse events in man.

C. Kirton, G. Bannish, D. Gliddon, 2011, Bioanalysis.

The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primates.

Jennifer Sims, Paul Baldrick, Kathryn L Chapman, 2012, Regulatory toxicology and pharmacology : RTP.

Considerations in the Design of Non-Clinical Development Programmes to Support Non-Viral Genetically Modified Mesenchymal Stromal Cell Therapies

Lee A Coney, V. Iansante, A. Brooks, 2021, Pharmaceutics.

Preclinical development of monoclonal antibodies

Ian Ragan, Kathryn Chapman, Colin Green, 2009, mAbs.

The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primates.

Kathryn L Chapman, N. Pullen, C. Bowman, 2012, Regulatory toxicology and pharmacology : RTP.